Clinical Tests on Silicon Reveals Antifuse Technology is Scalable
Santa Clara-based Kilopass Technology recently declared that its primary trial chip silicon on TSMC 28nm High-K Metal Gate (HKMG) has revealed that the company’s 2T antifuse technology can be modified to HKMG.
Silicon data reveals that the current 2T bit cell functions well on 28HKMG and can match 22nm and beyond.
Harry Luan, Kilopass chief executive officer says the chip silicon consisted of the multiple 2T bit cell for basic trial and cell modeling. The trial reveals that the technology in HKMG distributes the programming smoothly without impacting its behavior. It displays reduced gate leakage, which leads to an enhanced read margin and high inbound output.
The company’s integrated NVM has been used in standard CMOS removing the need for extra backend procedures. It can be produced in large volumes. It complies with the foundry DFM design regulations and uses devices from the foundry. It does not need extra tolerance or process control.
Source: http://www.kilopass.com/
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Chai, Cameron. (2019, February 12). Clinical Tests on Silicon Reveals Antifuse Technology is Scalable. AZoNano. Retrieved on March 03, 2026 from https://www.azonano.com/news.aspx?newsID=22173.
MLA
Chai, Cameron. "Clinical Tests on Silicon Reveals Antifuse Technology is Scalable". AZoNano. 03 March 2026. <https://www.azonano.com/news.aspx?newsID=22173>.
Chicago
Chai, Cameron. "Clinical Tests on Silicon Reveals Antifuse Technology is Scalable". AZoNano. https://www.azonano.com/news.aspx?newsID=22173. (accessed March 03, 2026).
Harvard
Chai, Cameron. 2019. Clinical Tests on Silicon Reveals Antifuse Technology is Scalable. AZoNano, viewed 03 March 2026, https://www.azonano.com/news.aspx?newsID=22173.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.